CC, Romulo, Shearman, V&A guide $3.9 bln Philippine network financing
Clifford Chance and Romulo Mabanta Buenaventura Sayoc & de los Angeles have advised the lenders on the $3.9 billion financing of Dito Telecommunity’s 4G and 5G telecommunications network in the Philippines, with Shearman and Sterling and Villaraza & Angangco advising Dito.
CAM, S&R act on Tata Technologies’ planned $366 mln IPO
Cravath, Swaine & Moore and Cyril Amarchand Mangaldas are advising India’s Tata Technologies on its planned 30.4-billion-rupee ($366 million) initial public offering, with Latham & Watkins and S&R Associates acting for the bookrunning lead managers JM Financial and Citigroup Global Markets India.
Shearman, AMT, White & Case, MHM act as Japan’s Benesse goes private for $1.78 bln
Shearman & Sterling and Anderson Mori & Tomotsune are advising Japanese educational services provider Benesse Holdings on a 270-billion-yen ($1.78 billion) management buyout (MBO) plan proposed by Swedish investment house EQT AB Group, represented by White & Case. Mori Hamada & Matsumoto act for the all stakeholders on this MBO scheme.
Wilson Sonsini, Davis Polk, Fangda, Jingtian on $470 mln WuXi XDC Hong Kong IPO
PRC law firm Fangda Partners and U.S. law firm Wilson Sonsini Goodrich & Rosati have advised Chinese medical research group WuXi XDC on its $470 million Hong Kong IPO, the third-largest new share sale in the city in 2023. Davis Polk & Wardwell and Jingtian & Gongcheng acted for the underwriters.
Sidley, CC act on $650 mln Singapore green infra deal
U.S. law firm Sidley Austin has represented infrastructure-focused private equity firm Stonepeak on its $650 million investment in Singapore-based green infrastructure investment firm AGP Sustainable Real Assets, which was advised by Clifford Chance.
Skadden, Freshies lead on HK’s largest IPO in 2023
U.S. law firm Skadden, Arps, Slate, Meagher & Flom and PRC firm Jia Yuan Law Offices are advising Chinese home-appliance maker Midea Group on its planned $1 billion initial public offering, expected to be the first billion-dollar IPO in Hong Kong this year.
Goodwin, MoFo, Slaughters guide $478 mln bio-pharma acquisition
U.S. law firm Morrison Foerster has advised Japan’s Kyowa Kirin on its $477.6 million acquisition of British biopharmaceutical company Orchard Therapeutics, which was represented by Goodwin Procter. Slaughter & May was Orchard’s UK legal advisor.